Frontiers in Immunology · 2012 · 51 citations · 150 references
Veterinary MedicineImmunologyInfectious DiseasesImmunizationVaccine ImmunologyVaccinologyAdaptive Immune ResponsesImmunopathology Of Parasitic DiseaseProtective ImmunityProtozoan ImmunologyVaccinationVaccine-preventable DiseasesAdaptive Immunity To Protozoan ParasitesImmunopathology Of LeishmaniasisLeishmania ImmunoregulationLeishmaniasis Of The SkinLeishmaniasis PathogenesisLeishmaniasis PathologyProtective Correlates Of ImmunityVaccination Strategies
Although a great deal of knowledge has been gained from studies on the immunobiology of leishmaniasis, there is still no universally acceptable, safe, and effective vaccine against the disease. This strongly suggests that we still do not completely understand the factors that control and/or regulate the development and sustenance of anti-Leishmania immunity, particularly those associated with secondary (memory) immunity. Such an understanding is critically important for designing safe, effective, and universally acceptable vaccine against the disease. Here we review the literature on the correlate of protective anti-Leishmania immunity and vaccination strategies against leishmaniasis with a bias emphasis on experimental cutaneous leishmaniasis.
150
IL-10 acts on the antigen-presenting cell to inhibit cytokine production by Th1 cells
David Fiorentino, Albert Zlotnik, Paulo Vieira et al. · The Journal of Immunology · 1991 · 1.9K citations · Full text
CD4+CD25+ regulatory T cells control Leishmania major persistence and immunity
Yasmine Belkaid, Ciriaco A. Piccirillo, Susana Méndez et al. · Nature · 2002 · 1.7K citations
Frederick P. Heinzel, M D Sadick, B J Holaday et al. · The Journal of Experimental Medicine · 1989 · 1.5K citations · Full text